Physician profile
Aaron D Berger
NPI 1720122005
$582,717.61
in general payments reported to CMS, 2019-2025
69 companies · $177K in 2025
The $177K reported for 2025 was more than what 99% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $62K · 2020: $48K · 2021: $26K · 2022: $38K · 2023: $104K · 2024: $127K · 2025: $177K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $262K · Consulting Fee: $71K · Travel and Lodging: $33K · Food and Beverage: $26K · Honoraria: $16K · Education: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $262,002.79 |
| Consulting Fee | $70,511.82 |
| Travel and Lodging | $32,908.56 |
| Food and Beverage | $25,942.88 |
| Honoraria | $16,340.00 |
| Education | $475.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $215,798.09 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Bayer Healthcare Pharmaceuticals INC. | $80,939.62 | 2019-2025 | |
| Astellas Pharma US INC | $80,550.28 | 2019-2025 | Xtandi, Myrbetriq |
| Ferring Pharmaceuticals INC. | $42,122.55 | 2019-2025 | Adstiladrin |
| Pfizer INC. | $40,881.81 | 2019-2025 | |
| Accord Healthcare, INC. | $32,856.76 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $20,525.74 | 2023-2025 | Orgovyx, Gemtesa |
| Bioprotect Medical, INC. | $17,050.12 | 2024-2025 | Bioprotect Balloon Implant System |
| Myovant Sciences INC. | $9,441.52 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $6,354.56 | 2019-2025 | Provenge |
| Urogen Pharma, INC. | $4,888.90 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $4,479.73 | 2020-2025 | Lynparza, Imfinzi |
| Bk Medical Holding Company INC. | $3,200.00 | 2020 | |
| Photocure INC | $2,250.00 | 2022 | |
| Pharmaand Gmbh | $2,229.04 | 2024 | Rubraca |
Show all 68 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,945.71 | 2019-2025 | Spaceoar Vue System - 10ml, Rezum Generator, Greenlight Xps |
| Coloplast Corp | $1,802.81 | 2019-2024 | Coloplast Tfl Drive, Titan |
| Neotract INC. | $1,451.29 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $1,338.52 | 2019-2025 | |
| Blue Earth Diagnostics | $1,016.59 | 2019-2024 | |
| Abbvie INC. | $987.25 | 2019-2025 | Botox |
| Antares Pharma, INC. | $919.98 | 2019-2025 | Xyosted |
| Teleflex LLC | $902.46 | 2021-2024 | Urolift |
| Verity Pharmaceuticals INC. | $876.03 | 2022-2025 | Trelstar, Tlando |
| Myriad Genetic Laboratories, INC. | $851.11 | 2020-2025 | Prolaris, Myrisk, Bracanalysis Cdx |
| Merck Sharp & Dohme LLC | $668.93 | 2020-2025 | Lynparza, Keytruda, Welireg |
| Novartis Pharmaceuticals Corporation | $588.93 | 2022-2025 | |
| Srs Medical Systems, INC. | $564.73 | 2020-2023 | Urocuff |
| Calyxo, INC. | $537.15 | 2024-2025 | Cvac Aspiration System |
| Olympus America INC. | $486.90 | 2019-2025 | Itind System, Soltive, Cysto-Nephro Videoscope |
| Palette Life Sciences, INC. | $400.15 | 2021-2023 | |
| Amgen INC. | $374.72 | 2019-2022 | |
| Intuitive Surgical, INC. | $341.81 | 2022-2024 | |
| Allergan, INC. | $273.15 | 2019-2022 | |
| Ambu INC. | $230.90 | 2020-2022 | |
| Telix Pharmaceuticals | $228.66 | 2022-2025 | Illuccix |
| Procept Biorobotics Corporation | $207.20 | 2021-2024 | Aquabeam System |
| Progenics Pharmaceuticals, INC. | $182.23 | 2021-2025 | Pylarify |
| Laborie Medical Technologies Corp. | $155.25 | 2024 | Optilume Bph Drug Coated Balloon Catheter, Endosheath Technology |
| Tolmar, INC. | $154.75 | 2023-2025 | Eligard |
| C. R. Bard, INC. & Subsidiaries | $151.60 | 2024 | Bard Urinary Drainage Bag |
| Clarus Therapeutics INC. | $143.57 | 2021 | |
| Foundation Medicine, INC. | $110.40 | 2021-2023 | |
| Tolmar Pharmaceuticals, INC. | $104.29 | 2020-2022 | |
| Travere Therapeutics, INC. | $100.21 | 2019-2021 | |
| Ge Healthcare | $97.43 | 2025 | |
| Urovant Sciences INC | $92.84 | 2021-2022 | |
| Genzyme Corporation | $86.07 | 2020-2022 | |
| Endo Pharmaceuticals INC. | $78.89 | 2019-2023 | Aveed, Edex, Xiaflex |
| Endo USA, INC. | $76.13 | 2024 | Xiaflex |
| Tempus Ai, INC | $71.18 | 2024 | |
| Sun Pharmaceutical Industries INC. | $70.52 | 2019-2025 | |
| Immunitybio, INC. | $64.30 | 2025 | |
| Cardinal Health 414 LLC | $58.03 | 2022-2023 | |
| Healthtronics Stone Solutions, LLC | $56.04 | 2025 | Dornier Medtech, Dornier Medtech, Cvac Aspiration System |
| Avyxa Pharma, LLC | $38.37 | 2025 | |
| 180 Medical, INC. | $38.15 | 2019-2021 | |
| Isoray, INC | $30.09 | 2020 | |
| Agiliti Surgical, INC. | $28.82 | 2023 | Sonablate |
| Angiodynamics, INC. | $28.40 | 2021 | |
| Convatec INC. | $27.25 | 2024 | |
| Amniox Medical, INC. | $21.51 | 2019 | |
| Profound Medical Corp. | $17.72 | 2025 | Tulsa-Pro |
| Edap Technomed INC | $16.62 | 2023 | |
| Lantheus Medical Imaging, INC. | $15.77 | 2024 | |
| Cook Medical LLC | $13.04 | 2023 | Resonance |
| Metuchen Pharmaceuticals | $12.51 | 2019 | |
| Avadel Specialty Pharmaceuticals, LLC | $11.93 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$19,000.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Berger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.